期刊文献+

胆舒胶囊预防腹腔镜胆囊切除术后综合征的可行性 被引量:9

原文传递
导出
摘要 [目的]观察胆舒胶囊预防腹腔镜胆囊切除术后综合征的可行性。[方法]选取均经MRCP检查排除胆总管结石及管肿瘤的慢性结石性胆囊炎患者290例,分为观察组(148例)与对照组(142例),所选患者均予以行腹腔镜胆囊切除术治疗。观察组患者在治疗前1周及治疗后2周服用胆舒胶囊,对照组在治疗后第3天开始服用胆舒胶囊2周;2组服用方法均为3次/d,每次2粒,饭后服用。观察并比较2组治疗2周后腹腔镜胆囊切除术后综合征的发生率。[结果]观察组腹腔镜胆囊切除术后综合征发生率为13.5%,对照组为26.7%,观察组患者的腹腔镜胆囊切除术后综合征的发生率显著低于对照组,2组比较差异有统计学意义(P<0.05)。[结论]:腹腔镜胆囊切除术前给予胆舒胶囊能有效降低腹腔镜胆囊切除术后综合征的发生率。
出处 《临床消化病杂志》 2016年第4期254-255,共2页 Chinese Journal of Clinical Gastroenterology
  • 相关文献

参考文献8

二级参考文献11

  • 1DU Wei-Dong,ZHANG Yue-E,ZHAl Wei-Rong and ZHOU Xiao-Mei(Department of Pathology, Shanghai Medical University, Shanghai200032, China)(National Laboratory for Oncogenes and Related Genes, ShanghaiCencer Institute)See invited commentary on page 388.Dynamic changes of typeⅠ,Ⅲand N collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis[J].World Journal of Gastroenterology,1999,5(5):397-403. 被引量:47
  • 2László Madácsy,Roland Fejes,Gábor Kurucsai,Ildikó Joó,András Székely,Viktória Bertalan,Attila Szepes,János Lonovics.Characterization of functional biliary pain and dyspeptic symptoms in patients with sphincter of Oddi dysfunction:Effect of papillotomy[J].World Journal of Gastroenterology,2006,12(42):6850-6856. 被引量:33
  • 3赵景涛.消化内科分册[M].北京:北京科技出版社.2005:386.
  • 4Galbfach PJ, Kolaci riska MB, Flont PA, et al. Gastric complaints or post cholecystectomy syndrome?[J]. Pol Merkur Lekarski, 2008, 25(147): 221-225.
  • 5Macaron C, Oadeer MA, Varao JJ. Recurrent abdominal rain after laparosconic cholecystectomy [J]. Cleve Clin J Med, 2011, 78(3): 171-178.
  • 6Sadowitz B, Azer W, Neulander O. A dilated cystic duct stump as a cause of postcholecvstectomv syndrome [J]. Am Sura, 2011, 77 (4): 67-68.
  • 7Jaunoo SS, Mohandas S, Almond LM. Posteholecvstectomy syndrome (PCS) [J]. Int J Surg, 2010, 8(1): 15-17.
  • 8Baillie J. Sphincter of Oddi dysfunction [J]. Curr Castroenterol Rep, 2010,12(2): 130-134.
  • 9Cheon YK, Cho YD, Moon JH, et al. Efier.ts of vardenafil, a phosphodiesterase tYre-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction [J]. Castrointest Endosc, 2009, 69(6): 111-116.
  • 10Mechetina TA, Bvstrovskaia EV, Il'chenko AA. Rationale for the allocation of clinical variants of the postcation of elinical of the posteholecystectomical syndrorne associated with hacterial overarowth in the small intestine [J]. Eksr Klin Gastroenterol, 2011(4): 37-43.

共引文献136

同被引文献153

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部